​

BioLife Solutions (BLFS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BLFS Stock Forecast

BioLife Solutions (BLFS) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $30.00 and a low of $30.00. This represents a 36.92% increase from the last price of $21.91.

$15 $18 $21 $24 $27 $30 High: $30 Avg: $30 Low: $30 Last Closed Price: $21.91

BLFS Stock Rating

BioLife Solutions stock's rating consensus is Buy, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 17 0 17 Strong Sell Sell Hold Buy Strong Buy

BLFS Price Target Upside V Benchmarks

TypeNameUpside
StockBioLife Solutions36.92%
SectorHealthcare Stocks 35.25%
IndustryMedical Instruments & Supplies Stocks34.02%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$30.00$30.00
Last Closing Price$21.91$21.91$21.91
Upside/Downside-36.92%36.92%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2527---9
Mar, 2528---10
Feb, 2528---10
Jan, 2528---10
Dec, 2428---10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 05, 2025H.C. Wainwright$30.00$26.2514.29%36.92%
Nov 15, 2024Jacob JohnsonStephens$30.00$21.5839.02%36.92%
Aug 12, 2024Matt HewittCraig-Hallum$30.00$25.2518.81%36.92%
Apr 04, 2024Matthew StantonJefferies$22.00$17.3227.02%0.41%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 05, 2025H.C. WainwrightBuyBuyhold
Nov 15, 2024StephensOverweightOverweighthold
Nov 13, 2024Cowen & Co.BuyBuyhold
Sep 30, 2024H.C. WainwrightBuyinitialise
Aug 12, 2024Craig-HallumBuyBuyhold
Jul 17, 2024Cowen & Co.BuyBuyhold
May 13, 2024BenchmarkBuyupgrade
Apr 04, 2024JefferiesBuyinitialise
Apr 25, 2022OppenheimerOutperformupgrade

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.10$-0.22$-3.29$-1.52$-0.44----
Avg Forecast$0.11$-0.01$-2.25$-1.57$-0.45$-0.17$0.08$0.54$0.99
High Forecast$0.12$-0.01$-1.91$-1.48$-0.42$0.09$1.09$0.58$1.06
Low Forecast$0.11$-0.01$-2.47$-1.67$-0.48$-0.55$-0.94$0.51$0.94
Surprise %-9.09%2100.00%46.22%-3.18%-2.22%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$48.09M$119.16M$161.76M$143.27M$82.25M----
Avg Forecast$46.92M$117.66M$160.90M$143.94M$104.47M$96.10M$115.50M$141.14M$170.57M
High Forecast$48.91M$122.64M$172.93M$151.68M$112.97M$101.95M$117.02M$148.74M$179.75M
Low Forecast$45.47M$114.03M$142.16M$138.21M$80.76M$92.15M$113.97M$135.53M$163.78M
Surprise %2.48%1.27%0.53%-0.46%-21.27%----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.67M$-8.38M$-139.81M$-66.43M$-20.18M----
Avg Forecast$4.81M$18.28M$19.99M$-66.43M$-19.67M$-9.17M$622.50K$23.82M$43.28M
High Forecast$5.07M$28.18M$33.03M$-33.67M$-18.36M$4.09M$47.74M$25.26M$46.31M
Low Forecast$4.62M$8.38M$6.94M$-99.19M$-20.99M$-23.96M$-40.92M$22.39M$41.04M
Surprise %-44.54%-145.86%-799.42%-2.59%----

BLFS Forecast FAQ

Is BioLife Solutions stock a buy?

BioLife Solutions stock has a consensus rating of Buy, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that BioLife Solutions is a favorable investment for most analysts.

What is BioLife Solutions's price target?

BioLife Solutions's price target, set by 17 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $30 at the low end to $30 at the high end, suggesting a potential 36.92% change from the previous closing price of $21.91.

How does BioLife Solutions stock forecast compare to its benchmarks?

BioLife Solutions's stock forecast shows a 36.92% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical instruments & supplies stocks industry (34.02%).

What is the breakdown of analyst ratings for BioLife Solutions over the past three months?

  • April 2025: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is BioLife Solutions’s EPS forecast?

BioLife Solutions's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.17, marking a -61.36% decrease from the reported $-0.44 in 2024. Estimates for the following years are $0.08 in 2026, $0.54 in 2027, and $0.99 in 2028.

What is BioLife Solutions’s revenue forecast?

BioLife Solutions's average annual revenue forecast for its fiscal year ending in December 2025 is $96.1M, reflecting a 16.83% increase from the reported $82.25M in 2024. The forecast for 2026 is $115.5M, followed by $141.14M for 2027, and $170.57M for 2028.

What is BioLife Solutions’s net income forecast?

BioLife Solutions's net income forecast for the fiscal year ending in December 2025 stands at $-9.174M, representing a -54.55% decrease from the reported $-20.184M in 2024. Projections indicate $622.5K in 2026, $23.82M in 2027, and $43.28M in 2028.